Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara L F Kaplan

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Current Protocols in Toxicology|March 8, 2018
Evaluation of Marijuana Compounds on Neuroimmune Endpoints in Experimental Autoimmune EncephalomyelitisBarbara L F Kaplan
Pharmacology & Therapeutics|December 25, 2012
The role of CB1 in immune modulation by cannabinoidsBarbara L F Kaplan
Virulence|January 18, 2018
Endocannabinoid engagement of CB<sub>2</sub> regulates RSV-induced immunityBarbara L F Kaplan
Cannabis and Cannabinoid Research|May 17, 2021
The CB<sub>1</sub> Receptor Differentially Regulates IFN-γ Production <i>In Vitro</i> and in Experimental Autoimmune EncephalomyelitisJames M Nichols, Barbara L F Kaplan
Advances in Pharmacology (San Diego, Calif.)|June 8, 2021
Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic applicationNorbert E Kaminski, Barbara L F Kaplan
Cannabis and Cannabinoid Research|April 24, 2020
Immune Responses Regulated by CannabidiolJames M Nichols, Barbara L F Kaplan
Environmental Health Perspectives|March 28, 2023
Invited Perspective: Environmental Chemical-Sensing AHR Remains an Enigmatic Key Player in ToxicologyBarbara L F Kaplan, B Paige Lawrence
Neuroimmunomodulation|October 12, 2023
Age-Dependent Effects of Transgenic 2D2 Mice Used to Induce Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 MiceJames M Nichols, Barbara L F Kaplan
Toxicology and Applied Pharmacology|May 14, 2026
Indole-3-Carbinol (I3C) suppression of IgG2b-triggered signaling in innate cells involves early suppression of p-AktArpita Deb, Audrey Miceli, Barbara L F Kaplan
International Immunopharmacology|February 9, 2024
Development of an in vitro peptide-stimulated T cell assay to evaluate immune effects by cannabinoid compoundsOlivia Cresswell, Karis Blankenship, Barbara L F Kaplan
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Current Protocols in Toxicology|March 8, 2018
Evaluation of Marijuana Compounds on Neuroimmune Endpoints in Experimental Autoimmune EncephalomyelitisBarbara L F Kaplan
Pharmacology & Therapeutics|December 25, 2012
The role of CB1 in immune modulation by cannabinoidsBarbara L F Kaplan
Virulence|January 18, 2018
Endocannabinoid engagement of CB<sub>2</sub> regulates RSV-induced immunityBarbara L F Kaplan
Cannabis and Cannabinoid Research|May 17, 2021
The CB<sub>1</sub> Receptor Differentially Regulates IFN-γ Production <i>In Vitro</i> and in Experimental Autoimmune EncephalomyelitisJames M Nichols, Barbara L F Kaplan
Advances in Pharmacology (San Diego, Calif.)|June 8, 2021
Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic applicationNorbert E Kaminski, Barbara L F Kaplan
Cannabis and Cannabinoid Research|April 24, 2020
Immune Responses Regulated by CannabidiolJames M Nichols, Barbara L F Kaplan
Environmental Health Perspectives|March 28, 2023
Invited Perspective: Environmental Chemical-Sensing AHR Remains an Enigmatic Key Player in ToxicologyBarbara L F Kaplan, B Paige Lawrence
Neuroimmunomodulation|October 12, 2023
Age-Dependent Effects of Transgenic 2D2 Mice Used to Induce Passive Experimental Autoimmune Encephalomyelitis in C57BL/6 MiceJames M Nichols, Barbara L F Kaplan
Toxicology and Applied Pharmacology|May 14, 2026
Indole-3-Carbinol (I3C) suppression of IgG2b-triggered signaling in innate cells involves early suppression of p-AktArpita Deb, Audrey Miceli, Barbara L F Kaplan
International Immunopharmacology|February 9, 2024
Development of an in vitro peptide-stimulated T cell assay to evaluate immune effects by cannabinoid compoundsOlivia Cresswell, Karis Blankenship, Barbara L F Kaplan
Pageof 8